1-3 of 3
J Peter Donnelly, PhD
Close
Sort by
Journal Articles

A Double-Blind, Multicentre, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome®) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard trial)

Oliver Cornely, MD, Thibaut Leguay, MD, Johan Maertens, MD, Carlo Castagnola, MD, Achilles Anagnostopoulos, Bernadino Allione, MD, Claus Peter Heussel, MD, J Peter Donnelly, PhD, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, MD, Nicola Goekbuget, MD
Journal: Blood
Blood (2014) 124 (21): 3646.
https://doi.org/10.1182/blood.V124.21.3646.3646
Published: 2014
Journal Articles

The Relationship between CRP, Citrulline and Bacteremia among Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma.

Alexandra H.E. Herbers, MD, J. Peter Donnelly, PhD, Ben E. de Pauw, MD PhD, Nicole N.A. Blijlevens, MD PhD
Journal: Blood
Blood (2006) 108 (11): 5435.
https://doi.org/10.1182/blood.V108.11.5435.5435
Published: 2006
Journal Articles

The Peptide hLF1-11 as Broad Spectrum Antmicrobial Prophylaxis in HSCT Patients.

Marty Wulferink, PhD, Carlo P. Brouwer, Astrid M.C. Sluiter-van Dijk, PhD, Nicole N.A. Blijlevens, PhD, MD, J. Peter Donnelly, PhD, MD, Markwin P. Velders, PhD
Journal: Blood
Blood (2005) 106 (11): 3241.
https://doi.org/10.1182/blood.V106.11.3241.3241
Published: 2005